Non small cell carcinoma
The importance of EGFR mutation testing in squamous cell carcinoma or non-small cell carcinoma favor squamous cell carcinoma diagnosed from small lung biopsies
... in small biopsy specimens may come from either ADC or SqCC component ...in small biopsy specimens is misdiagnosed as SqCC or poorly differentiated SqCC re- ferring to non-small cell ...
8
Histopathological Profile of Lung Tumors On Ct/Usg Guided Core Needle Biopsy Specimens
... The expression of cytokeratins (CK) in human lung cancers is studied using monoclonal antibodies to cytokeratins 4,5,7,8,10,18 and 19.( Jos LV Broers et al) 16 .When applied to adenocarcinoma,high level of cytokeratins ...
91
Case Report Parotid gland and cerebellum metastasis of lung cancer: a case report
... Lung carcinoma is the most frequent malignant disease and the most common cause of cancer death in the ...Squamous cell carcinomas accounts for ap- proximately 30% of all non-small cell ...
7
Clinical potential of necitumumab in non-small cell lung carcinoma
... advanced non-small cell lung cancer (NSCLC) are highly needed, particularly for the treatment of patients with squamous cell ...in non-squamous histology, the receptor itself is more ...
11
Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type
... The SMARCA4 gene encodes an ATP-dependent heli- case BRG1 which belongs to the SWI/SNF (mating type SWItching defective/Sucrose Non Fermenting) complex and is involved in epigenetic regulation of gene expres- sion ...
6
Basis of PD1 PD-L1 Therapies
... are small non-coding RNAs of about 20 nucleotides in length and represent next to RNA binding proteins (RBPs) the main posttranscriptional regulators of gene expression by binding to the 3 0 UTR of target ...
14
Abstract
... firmed non−small−cell lung cancer (65 men and 30 women, mean age: ...squamous cell carcinoma in 59 patients, adenocar− cinoma in 26 patients, large−cell carcinoma in 5 ...
6
Spotlight on necitumumab in the treatment of non-small-cell lung carcinoma
... EGFR expression is ubiquitous in NSCLC, and use of this pathway to target cancer cells has been an area of interest. Necitumumab is a second-generation human monoclonal antibody that has shown promise in the treatment of ...
7
Small RNAs in metastatic and non-metastatic oral squamous cell carcinoma
... MiR-130b was also found up regulated in HNSCC when compared to cancer-free tissues [32, 24] and it is involved in immortalization of normal oral keratinocytes [33]. Its possible role in metastasis was recently ...
15
Studying combined effects of chemotherapy and radiotherapy on blood cell counts in lung cancer patients
... cancer; small cell lung carcinoma (SCLC) and non-small cell lung carcinoma ...For small cell lung cancer chemotherapy is best technique but for ...
8
A study of Expression of Epidermal growth factor receptor (EGFR) in Lung Cancers.
... into small cell carcinoma of lung and non small cell lung malignancies based on the available modality of treatment ...of non small cell subtypes so that ...
152
Lung cancer cytology: potential pitfalls- a review
... squamous cell carcinomas, adenocarcinomas, small cell carcinomas, and large cell ...mous cell carcinoma, adenocarcinoma, and large cell carcinomas are very similar, they ...
6
Non-small-cell lung carcinoma: role of the Notch signaling pathway
... critical cell fate decisions both in compart- ments that are undergoing differentiation and in pluripotent progenitor ...for non-canonical Notch ...in non-small-cell lung ...
11
Docetaxel in the treatment of non-small cell lung carcinoma: an update and analysis
... a small incre- mental survival benefit compared to another regimen, it is important to consider how the toxicities of the regimens affect the quality of life of ...
14
Protein signatures of molecular pathways in non-small cell lung carcinoma (NSCLC): comparison of glycoproteomics and global proteomics
... NSCLC is the most common morphological type of lung carcinoma (85–90%) and it consists of two major histological subtypes (ADC: 40–50%; SqCC: 25–30%) and several other subtypes (5%) [10]. The development and ...
15
Cross-Platform Comparison of Four Leading Technologies for Detecting EGFR Mutations in Circulating Tumor DNA from Non-Small Cell Lung Carcinoma Patient Plasma
... In conclusion, our study provides a comparative evaluation of four major technologies, ADx-ARMS, cobas-ARMS, ddPCR and Firefly NGS, for EGFR mutation detection in ctDNA from NSCLC patients. Despite the limited sample ...
10
Personalized medicine and treatment approaches in non-small-cell lung carcinoma
... Abstract: Chemotherapy has been the traditional backbone for the management of metastatic lung cancer. Multiple trials have shown the benefits of treatment with platinum doublets in lung cancer. This “one treatment fits ...
11
Molecular features of giant-cell carcinoma of the lung: a case report and literature review
... GCCL is a poorly differentiated non-small-cell lung cancer. Throughout the decades, the classification and concepts per- taining to the histogenesis have been controversial before the five subtypes ...
6
Original Article Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis
... 1 non-small cell lung carcinoma and that ALDH1 expression overlapped with CD133 in a small subset of ...1 non-small cell lung carcinoma ...
13
Utility of five commonly used immunohistochemical markers TTF-1, Napsin A, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases
... into small cell lung carcinoma (SCLC) and non-small cell lung carcinoma ...adeno- carcinoma (50-70%), squamous cell carcinoma (20-30%) and other ...
13